(Q34722415)

English

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Henry Seth Friedman

7

object named as

Henry S Friedman

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Darell D. Bigner

17

object named as

Darell D Bigner

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Annick Desjardins

5

object named as

Annick Desjardins

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

6

object named as

Allan H Friedman

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

David A Reardon

12

object named as

David A Reardon

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Roger E McLendon

10

object named as

Roger E McLendon

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

4

object named as

April Coan

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

James J Vredenburgh

16

object named as

James J Vredenburgh

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

James H. Herndon

9

object named as

James E Herndon

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Robert J Schmittling

14

object named as

Robert Schmittling

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Duane A Mitchell

11

object named as

Duane A Mitchell

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Kenneth D Aldape

2

object named as

Kenneth D Aldape

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

13

object named as

Raymond Sawaya

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

15

object named as

Weiming Shi

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

author name string

John H Sampson

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Gary E Archer

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Mark R Gilbert

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Amy B Heimberger

18

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

10 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

324-333

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

A causal link between lymphopenia and autoimmunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Constitutive EGFR signaling confers a motile phenotype to neural stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

T cell homeostatic proliferation elicits effective antitumor autoimmunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Expression of oncogenic epidermal growth factor receptor family kinases induces paclitaxel resistance and alters beta-tubulin isotype expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Phase I trial of temozolomide using an extended continuous oral schedule.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Structural alterations of the epidermal growth factor receptor gene in human gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

7 July 2018

Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOQ157

21 January 2018

Radiation-induced activation of a common variant of EGFR confers enhanced radioresistance

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOQ157

21 January 2018

How lymphotoxic is dose-intensified temozolomide? The glioblastoma experience

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOQ157

21 January 2018

Lymphocyte homeostasis

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOQ157

21 January 2018

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials

1 reference

https://api.crossref.org/works/10.1093%2FNEUONC%2FNOQ157

21 January 2018

Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

26 October 2018

Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

26 October 2018

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3064599

26 October 2018

Identifiers

10.1093/NEUONC/NOQ157

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34722415&oldid=1747715098"